The
The results topped
The biopharmaceutical company posted revenue of
For the year, the company reported profit of
Bristol Myers expects full-year earnings in the range of
Bristol Myers shares have dropped 1% since the beginning of the year, while the S&P's 500 index has increased slightly more than 7%. The stock has climbed slightly more than 9% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
Copyright by Automated Insights, Inc. All rights reserved., source